Copyright
©The Author(s) 2025.
World J Gastrointest Pathophysiol. Sep 22, 2025; 16(3): 107954
Published online Sep 22, 2025. doi: 10.4291/wjgp.v16.i3.107954
Published online Sep 22, 2025. doi: 10.4291/wjgp.v16.i3.107954
Figure 1 Association of specific kirsten rat sarcoma viral oncogene homolog, neuroblastoma RAS viral oncogene homolog, and v-raf murine sarcoma viral oncogene homolog B1 hot-spot mutations with tumor’s pathological stage.
A statistically significant at P < 0.05. Regression models were adjusted for age at diagnosis, sex, race/ethnicity, primary tumor site, DNA mismatch repair status, familial cancer risk, number of comorbidities, and tobacco use. BRAF: V-raf murine sarcoma viral oncogene homolog B1; KRAS: Kirsten rat sarcoma viral oncogene homolog; NC: Not calculated; NRAS: Neuroblastoma RAS viral oncogene homolog; CI: Confidence interval; OR: Odds ratio; pT: Pathological stage.
Figure 2 Association of specific kirsten rat sarcoma viral oncogene homolog, neuroblastoma RAS viral oncogene homolog, and v-raf murine sarcoma viral oncogene homolog B1 hot-spot mutations with regional lymph node and distant metastasis.
A statistically significant at P < 0.05. Regression models were adjusted for age at diagnosis, sex, race/ethnicity, primary tumor site, DNA mismatch repair status, familial cancer risk, number of comorbidities, and tobacco use. BRAF: V-raf murine sarcoma viral oncogene homolog B1; KRAS: Kirsten rat sarcoma viral oncogene homolog; NC: Not calculated; NRAS: Neuroblastoma RAS viral oncogene homolog; CI: Confidence interval; OR: Odds ratio.
- Citation: Abdelgadir O, Kuo YF, Khan MF, Okorodudu AO, Cheng YWO, Dong J. Colorectal cancer tumor phenotypes associated with KRAS, NRAS, and BRAF hot-spot mutations. World J Gastrointest Pathophysiol 2025; 16(3): 107954
- URL: https://www.wjgnet.com/2150-5330/full/v16/i3/107954.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i3.107954